Clinical Trial

Nursing Care of Bipolar Patients With Sleeping Disorders Using Luminotherapy and /or Psychoeducation Program (BIPLUMINO)

Study acronym: BIPLUMINO
Recruiting
View on ClinicalTrials.gov →
Summary
Bipolar disorder affects more than 1% of the population. This pathology is considered as one of the most serious psychiatric disorder because of it is high suicide rates. It impacts patients life quality on many aspects, and specially their sleeping and circadian Rhythms. This can lead to more severe symptoms up to for thymic relapses. It was shown that Luminotherapy and Psychoeducation Program have a positive impact on these type of symptoms.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2021-06-07; most recent amendment 2026-01-12.
Status change: Not Yet Recruiting → Recruiting 2023-01-18
Trial Details
NCT Number NCT04917419
Lead Sponsor Centre Hospitalier Henri Laborit
Conditions Bipolar Disorder
Enrollment 170 participants
Start Date 2022-12-05
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-01-13